Thank you, operator, and good afternoon, everyone. Welcome to the Bionano third quarter 2024 financial results conference ...

Bionano Genomics Inc. (BNGO) stock has reached a new 52-week low, trading at $0.27. This latest price point marks a significant downturn for the company, which specializes in... Bionano Genomics ...

Investing.com – U.S. stocks were higher after the close on Monday, as gains in the Oil & Gas, Financials and Technology sectors led shares higher. At the close in NYSE, the Dow... Investing.com ...

Bionano Genomics BNGO will release its quarterly earnings report on Wednesday ... It's important for new investors to understand that guidance can be a significant driver of stock prices. In the ...

BTIG Research has recently reduced BioNano Genomics Inc (BNGO) stock to Neutral rating, as announced on September 10, 2024, according to Finviz. Earlier, on January 5, 2023, Scotiabank had initiated ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under Nasdaq rules for the purchase and sale of an ...

BioNano Genomics ( (BNGO) ) has shared an update. Bionano Genomics announced a $3 million registered direct offering involving the sale of ...

Q3 2024 revenue was $6.1 million, which comprises $6.6 million in core product and software sales which is offset by $0.5 million because of a ...

On Wednesday, BioNano Genomics Inc (BNGO) stock saw a modest uptick, ending the day at $0.3 which represents no change from the prior close of of $0.3. The stock opened at $0.3 and touched a low of $0 ...

The offering highlights Bionano’s strategic financial maneuvers to bolster its genomic solutions business. See more insights into BNGO stock on TipRanks’ Stock Analysis page.

This might drive the stock higher in the near term. SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and ...